Search results
28 lis 2023 · Young people, aged 15–24, account for around 27% of new HIV infections globally. Yet in eastern and southern Africa — the region of the world most severely affected by HIV — only 25% of ...
10 lip 2024 · GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing ...
Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology. Working like scissors, but at the molecular level, it cuts DNA...
26 mar 2024 · A patented HIV-virus-like-particle (HLP) can effectively 'shock and kill' latent HIV reservoir in people living with chronic HIV on cART, according to a study by an international team of researchers. HLP is an affordable and accessible biotherapeutic that can target different HIV subtypes and could lead to an HIV-1 cure.
24 lip 2024 · Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need for lifelong medications.
5 sie 2022 · Cabotegravir, an injectable antiviral, is more effective than oral pill in preventing HIV infection, but it is also more expensive. The WHO has recommended its use, but campaigners and researchers urge ViiV Healthcare to lower the price for low-income countries.
6 mar 2024 · Despite 20 years of failures in major HIV vaccine trials, researchers say recent advances have likely, hopefully, put them on the right track to develop a highly effective vaccine.
